Pancreatic cancer drug approved in 135 days, fastest FDA approval this year
JosephJacks_ · x · 2026-08-28
Daraxonrasib for pancreatic cancer secured FDA approval in just 135 days from data submission, marking the fastest approval of the year by far. Max Hodak commented on the speed.
More from Apps
- Dev newsletter: 'My AI assistant is turning into an operating system' — dSebastien · 2026-08-28
- ChatGPT Web App Adds Meetings Plugin for Recording & Transcripts — btibor91 · 2026-08-28
- Photoshop's New AI Assisted Editor Adjusts Lighting via Sliders — azed_ai · 2026-08-28
- Wanderboat AI demo: Searching for vibes via natural language — Aiden_Tech_Ai · 2026-08-28
- Integrating GPT Realtime Voice with FaceTime for One-Agent UX — alexcovo_eth · 2026-08-28
- Eachlabs launches video processing MCP for one-shot video editing — azed_ai · 2026-08-28